Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 307 results for "esbl"

Tailoring of Infection Control Measures According to ESBL Spec...

Generic epidemiological differences between extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (ESBL-EC) and Klebsiella pneumoniae (ESBL-KP), are poorly defined. Nonetheless, defining such differences and understanding their basis ... Infection Control Today, 1 week ago

1 images for "esbl"

Surgical Products, 1 month ago
Irish Independent

Disciplinary action in Savita case 'a cop out'

DISCIPLINARY action taken against a number of staff at University Hospital Galway (UHG) following the death of Savita Halappanavar has been slammed as a "total whitewash". The HSE said the disciplinary action against almost all of the nine staff has ...
 Irish Independent3 days ago

Identifying Resistant Infections in Hours With Inexpensive Lab Test

Modification of the protocol for a relatively new test for a dangerous form of antibiotic resistance has been done by researchers from Oregon State Public Health, and increased its specificity to 100 percent. Their research, confirming the ...
 MedIndia6 days ago Researchers modify protocol to test dangerous form of antibiotic resistance  News-Medical.Net1 week ago Inexpensive lab test identifies resistant infections in hours  EurekAlert!1 week ago Simple and inexpensive lab test identifies resistant infections in hours  Medical News Today5 days ago
PR Newswire

US FDA accepts Actavis' NDA for ceftazidime-avibactam

Actavis confirmed that the US Food and Drug Administration (US FDA) has accepted for filing Actavis' application for ceftazidime-avibactam, its investigational antibiotic for the treatment of patients with Complicated Urinary Tract Infections (cUTI) ...
 PharmaBiz1 week ago FDA accepts Actavis' NDA filing for ceftazidime-avibactam  Pharmaceutical Business Review6 days ago Actavis Announces FDA Acceptance of the NDA Filing for Ceftazidime-Avibactam, a Qualified Infectious Disease Product  Reliance Trust1 week ago ACTAVIS : Announces FDA Acceptance of the NDA Filing for Ceftazidime-Avibactam, a Qualified Infectious Disease Product  4 Traders1 week ago

Population Structure of Clinical Pseudomonas aeruginosa from West and Central African Countries

by Pascal Cholley, Roughyatou Ka, Christophe Guyeux, Michelle Thouverez, Nathalie Guessennd, Beniam Ghebremedhin, Thierry Frank, Xavier Bertrand, Didier Hocquet Background Pseudomonas aeruginosa ( PA ) has a non-clonal, epidemic population with a ...
 Plosone.org1 week ago
Irish Times

Capillary-Electrophoresis Mass Spectrometry for the Detection of Carbapenemases in (Multi-)Drug-Resistant Gram-Negative Bacteria

In a time in which the spread of multidrug resistant microorganisms is ever increasing, there is a need for fast and unequivocal identification of suspect organisms to supplement existing techniques in the clinical laboratory, especially in single ...
 Analytical Chemistry1 week ago Multidrug-Resistant K. pneumoniae Isolates  General Medicine eJournal2 weeks ago The global march of antibiotic-resistant bugs  Irish Times1 month ago Untreatable - 10 dangerous antibiotic-resistant infections  New Zealand Herald2 months ago

Karachi Stock Exchange Closing Rate of Financial Services dated 01-09-2014

Home ┬╗ General Business News By PPI News Agency Karachi, September 01, 2014 (PPI-OT): Company Name Turnover Prv.Rate Open Rate Highest Lowest Last Rate Diff. Financial Services AHL Arif Habib Ltd. ...
 Pakistan Press International1 week ago ´╗┐Karachi Stock Exchange Closing Rate of Financial Services dated 22-07-2014  Pakistan Press International1 month ago

Cubist's MAA for anti-bacterial agent receives EMA acceptance for review

Cubist Pharmaceuticals, Inc., a biopharmaceutical company, has received the European Medicines Agency, or EMA, acceptance for reviewing its marketing authorization application, or MAA, for its investigational anti-bacterial agent, ...
 Individual.com1 week ago EMA to review Cubist antibiotic  Hospital Pharmacy Europe2 weeks ago Cubist Gets EMA Acceptance for Review of MAA for Ceftolozane/Tazobactam  Individual.com2 weeks ago Cubist Highlights EMA Acceptance of Ceftolozane/Tazobactam Marketing Authorization Application for Review  Individual.com2 weeks ago

What You Missed From Regulatory Agencies Recently August 18-28, 2014

By , associate editor NICE Gives Nod Of Approval To Celgene's Revlimid NICE has published final draft guidance stating that Celgene's Revlimid for myelodysplastic syndromes will be available on the NHS in England. The recommendation applied to ...
 Pharmaceutical Online2 weeks ago

Allergan Receives Written Requests from Pershing Square; Cubist Announces EMA Acceptance of Ceftolozane/Tazobactam Marketing

Below is a look at some of the headlines for companies that made news in the healthcare sector on August 22, 2014. Allergan, Inc. (NYSE: AGN) confirmed that Pershing Square Capital Management, L.P. (Pershing Square) has delivered written ...
 BioMedReports3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less